Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.79% to 10556.17, DAX +0.80% to 24998.40, CAC40 +0.54% to 8361.46, STOXX 600 +0.45% to 621.29

Feb 17 ,2026

  • Synopsis:

    • European equity markets finished in positive territory. Real estate, health care stocks outperform; miners and food & beverage lag. Follows mostly mixed performance on Monday.

    • No meaningful development in the narrative. Recent focus has been on AI disruption risk, Mag 7 underperformance, elevated single-stock (and basket) volatility, defensives as a rotation beneficiary, BTD debates (lack of backstop for AI victims vs overall inflows), less-stretched sentiment and (some) positioning readings, solid macro data (particularly January employment and inflation)and elevated geopolitical tensions.

    • Macro focus on UK labor market ahead of tomorrow's key inflation update. Official data showed further cooling, reinforcing the view that slack is increasing. The ILO unemployment rate rose to a fresh cycle high of 5.2%, claimant count increased more than expected by 28.6K versus 22.8K forecast and prior 2.7K increase down from 17.9K. Germany's final January inflation print was confirmed at 2.1% y/y, matching preliminary reading and marking an uptick from Dec's 1.8%. ZEW expectations unexpectedly slipped to 58.3 in Feb from Jan's 59.6, missing consensus of 65.0 by 6.9 points-a notable downside surprise-tempering trader optimism for Europe's largest economy. Current conditions improved as forecast, up 6.8 points to -65.9, offering partial offset.

    • In earnings news, in the DACH region, DKSH Holding (DKSH.SW) and Basilea Pharmaceutica (BSLN.SW) reported FY earnings this morning, with the latter also issuing its agenda for 2030, indicating it expects to add CHF 600M in cumulative cash flows from Cresemba and Zevtera. Expect pressure on Flughafen Zurich (FHZN.SW) shares as airport tariffs have been cut by more than expected. In France, Aeroport de Paris (ADP.FP) released January traffic figures, whilst Vicat (VCT.FP) reported FY earnings. In Nordics, Sinch (SINCH.SS), Hacksaw (HACK.SS), and Truecaller (TRUE.B.SS) issued end of year figures. In the UK, InterContinental Hotels Group (IHG.LN), Boohoo Group Plc (DEBS.LN), and Antofagasta (ANTO.LN) are amongst others in the region to update investors with their latest numbers. BHP Group (BHP.LN) shares are trading higher in Australia as EPS & dividend ahead; copper strength offset weaker coal performance; silver streaming sale viewed positively. Elsewhere, Coca-Cola Europacific Partners (CCEP.NA) reported FY earnings, announced a €1B buyback and guided FY26 and Kerry Group (KRZ.ID) released FY numbers, announced a €300M share buyback and guided 2026 constant currency adjusted EPS growth of +6-10%.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, UK Jan CPI/RPI, PPI output/input, and France Jan final CPI.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Real Estate +1.83%, Health Care +1.41%, Banks +1.12%, Insurance +0.93%, Travel & Leisure +0.89%, Technology +0.81%, Media +0.79%, Retail +0.73%, Telecom +0.71%, Autos & Parts +0.68%

      • Underperformers:

        • Basic Resources (1.59%), Food & Beverage (0.94%), Oil & Gas (0.64%), Financial Svcs (0.16%), Construct & Mtls (0.11%), Ind Goods & Svcs (0.04%), Chemicals +0.03%, Utilities +0.39%, Persnl & HHold Goods +0.44%

    • Macro:

      • Central Banks:

      • EU:

        • EU weighs two-track approach to break economic reform deadlock -- Reuters

        • EU annual budget 2027: Council sets guidelines for next year's EU budget -- Council of the EU

      • UK:

        • Who's who in Reform UK's top team -- FT

        • UK unemployment rate hits near five-year high as wage growth slows -- BBC

        • Britain needs bold interest rate cuts to rescue its anaemic economy -- Telegraph

      • Germany:

        • German economy remains stuck and set for just 1% growth in 2026, chamber of commerce says -- Reuters

      • Italy

        • Italy to be an observer on Trump's board of peace, minister says-- Bloomberg

    • Company news:

      • Notable Gainers

        • +7.3% BAYN.GR (Bayer AG €46.18, +3.38) -- Bayer AG preparing to announce $10.5B settlement push to resolve current and future Roundup cases -- Bloomberg, citing sources

        • +7.3% DKSH.SW (DKSH Holding CHF61.70, +4.40) -- FY earnings

        • +6.2% SSPG.LN (SSP Group £2.00, +0.12) -- UBS upgrade

        • +5.2% CSN.LN (Chesnara £3.14, +0.16) -- acquires 100% of Scottish Widows Europe SA for tot. cash €110M

        • +5.1% HLAG.GR (Hapag-Lloyd €114.90, +5.60) -- merger agreement with ZIM Integrated Shipping Services

        • +5.1% AVOL.SW (Avolta CHF52.45, +2.52) -- UBS upgrade

        • +4.9% ERG.IM (ERG €22.38, +1.06) -- ERG exploring industrial alliances in renewables sector; A2A and Axpo emerging among hypothetical partners -- Corriere della Sera

        • +4.7% NOTE.SS (NOTE SEK169.80, +7.80) -- Nordea upgrade

        • +3.7% ITM.LN (ITM Power £0.66, +0.02) -- raises FY26 revenue guidance

        • +2.7% FHZN.SW (Flughafen Zuerich CHF249.80, +7.00) -- concluded negotiations on flight operations charges

        • +2.5% GSK.LN (GSK Plc £22.12, +0.55) -- Exdensur approved by EC; commences £0.45B fourth tranche of buyback program

        • +2.3% ONCIN.NO (BerGenBio NOK46.70, +1.01) -- Radspherin phase 1 ovarian cancer study follow-up data

      • Notable Decliners

        • -31.2% ALSN.SW (ALSO Holding CHF167.40, -60.40) -- FY earnings

        • -23.3% G5EN.SS (G5 Entertainment SEK56.90, -19.40) -- Q4 earnings

        • -16.0% DEBS.LN (Debenhams Group £0.21, -0.04) -- ~£35M equity fundraise

        • -14.3% SINCH.SS (Sinch SEK20.70, -3.36) -- FY earnings

        • -14.1% CAT.B.SS (Catella SEK22.60, -3.60) -- Q4 earnings

        • -11.8% BFF.IM (BFF Bank SpA €3.67, -0.45) -- response to media reports on Milan's Public Prosecutor's Office preliminary investigations

        • -7.5% FAG.SS (Fagerhult Group SEK39.05, -2.70) -- Q4 earnings

        • -6.9% SSH1V.FH (SSH Communications Security €2.37, -0.18) -- Q4 earnings

        • -6.1% KRZ.ID (Kerry Group €75.45, -4.75) -- FY earnings; new Chair

        • -5.4% BAHN.B.SS (Bahnhof SEK50.90, -2.90) -- Q4 earnings

        • -5.2% PLUS.LN (Plus500 £44.42, -2.44) -- holders sold 1.5M shares

        • -5.1% NRC.NO (NRC Group NOK9.08, -0.43) -- Q4 earnings

        • -4.8% ALFEN.NA (Alfen €9.07, -0.46) -- Oddo downgrade

        • -4.3% SINT.SS (SinterCast SEK87.00, -4.00) -- Q4 earnings

        • -3.7% ASPO.FH (Aspo €7.34, -0.28) -- Evli Bank downgrade

        • -3.5% FCT.IM (Fincantieri €16.26, -0.58) -- Mediobanca downgrade

        • -3.5% VCT.FP (Vicat €69.80, -2.60) -- FY earnings

        • -3.4% ANTO.LN (Antofagasta £35.93, -1.29) -- FY earnings

        • -3.0% ECOR.LN (Ecora Royalties £1.37, -0.04) -- FY earnings

        • -2.3% SPR.LN (Springfield Properties £1.21, -0.03) -- H1 earnings

        • -2.0% NOEJ.GR (Norma Group €15.52, -0.32) -- prelim. FY earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: ASR Nederland (ASRNL.NA), IMCD (IMCD.NA)

        • DACHs: Straumann Holding (STMN.SW), EFG International (EFGN.SW), Sunrise Communications (SUNN.SW), CPH Group (CPHN.SW), Wienerberger (WIE.AV), SAF-HOLLAND (SFQ.GR)

        • Denmark: FLSmidth & Co. (FLS.DC)

        • France: Orange (ORA.FP), Euronext (ENX.FP), Aeroport de Paris (ADP.FP), Covivio (COV.FP), Eramet (ERA.FP)

        • Norway: Zaptec (ZAP.NO), PhotoCure (PHO.NO), S.D. Standard (SDSD.NO)

        • Southern Europe: Naturgy Energy Group (NTGY.SM)

        • Sweden: L E Lundbergföretagen (LUND.B.SS), Castellum (CAST.SS), BioArctic (BIOA.B.SS), Scandic Hotels Group (SHOT.SS), Bravida Holding (BRAV.SS), OEM International (OEM.B.SS), Cibus Nordic Real Estate (CIBUS.SS), VBG Group (VBG.B.SS), Momentum Group (MMGR.B.SS), Nordrest Holding (NREST.SS), Kambi Group (KAMBI.SS), Orrön Energy (ORRON.SS), BICO Group (BICO.SS), SynAct Pharma (SYNACT.SS), SaltX Technology Holding (SALT.B.SS), Cinclus Pharma Holding (CINPHA.SS), Medivir (MVIR.SS), Isofol Medical (ISOFOL.SS)

        • UK: Glencore (GLEN.LN), BAE Systems (BA.LN), CRH (CRH.LN), Pan African Resources (PAF.LN), Conduit Holdings (CRE.LN)

  • Data:

    • Economics:

      • Germany

        • Feb

        • ZEW Economic Sentiment Indicator 58.3 consensus 65.2 and prior 59.6

        • ZEW Current Situation (65.9) vs consensus (65.7) and prior (72.7)

        • Jan CPI +2.1% y/y vs preliminary +2.1%

      • UK

        • Jan Claimant Count Change +28.6K vs consensus +22.8K and prior revised +2.7K from +17.9K

        • Dec Unemployment Rate 5.2% vs consensus 5.1% and prior 5.1%

    • Markets:

      • WTI Crude (26-Mar): ($0.65) or (1.03%) to $62.24

      • €-$ (0.0018) or (0.15%) to 1.1834

      • £-$ (0.0095) or (0.70%) to 1.3534

      • €-£ +0.0049 to 0.8745

      • S&P 500 +0.02%

      • Performance year-to-date:

        • FTSE 100: +6.29%

        • DAX: +2.07%

        • CAC: +2.60%

        • MIB: +1.82%

        • Stoxx 600: +4.91%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE